Complete Genomics and Velsera are collaborating to deliver an end-to-end genetic testing solution that integrates DNBSEQ™ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW) data ...
FRAMINGHAM, Mass., Dec. 17, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. It's been a long, long time since one of OVP Venture ...
Complete Genomics will share details of various multi-omics and spatial transcriptomics applications based on its sequencing technology at the 2024 American Society of Human Genetics (ASHG) Meeting.
About Complete Genomics Complete Genomics is a pioneering life sciences company that provides comprehensive sequencing solutions spanning sample and library preparation, lab automation, sequencing, ...
BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (SOPH) (Nasdaq: SOPH), a global leader in ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and Complete Genomics, USA, granting Swiss Rockets a perpetual, ...
BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (SOPH) (NASDAQ: SOPH), a global leader in ...
Complete Genomics DNBSEQ data and NVIDIA Parabricks yield deeper insights into genetic variants with deep learning SAN JOSE, Calif., Oct. 29, 2024 /PRNewswire/ -- Complete Genomics today announced an ...
Complete Genomics Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to
Add Yahoo as a preferred source to see more of our stories on Google. There is no cost or fee to you, so if you are an affected investor and want to learn more about the lawsuit or join the action, ...
Complete Genomics, the OVP Venture Partners-backed DNA sequencing company, is having a tough time of it following its initial public offering this week. Shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results